FdaApplication

NDA 203340

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAZURITY PHARMACEUTICALS INC
application_typeNDA
approval_date2013-05-10

Products (2)

ProductActive ingredientStrengthDosage form
NYMALIZENIMODIPINE6MG/MLSOLUTION;ORAL
NYMALIZENIMODIPINE3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION;ORAL

2 products